{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:49:42Z","timestamp":1791154182497,"version":"4.1.0"},"reference-count":74,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2013]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The clinical value of antiplatelet compounds strongly depends on the benefit-risk balance between their anti-thrombotic effects and the bleeding risk they incur. This ratio is especially important in the treatment of cerebro-vascular disease. Several novel compounds in clinical development hold promise to improve this benefit-risk ratio.<\/jats:p>","DOI":"10.1160\/th13-02-0084","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T15:46:43Z","timestamp":1381420003000},"page":"868-875","source":"Crossref","is-referenced-by-count":20,"title":["Novel antiplatelet drugs in clinical development"],"prefix":"10.1160","volume":"110","author":[{"given":"Martin","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"M\u00fcnch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"10.1160\/TH13-02-0084-1","unstructured":"Mackay J, Mensah G. The Atlas of heart disease and stroke. 1 ed. World Health Organisation; 2004"},{"key":"10.1160\/TH13-02-0084-2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2011.96"},{"key":"10.1160\/TH13-02-0084-3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2957"},{"key":"10.1160\/TH13-02-0084-4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31825498e8"},{"key":"10.1160\/TH13-02-0084-5","doi-asserted-by":"publisher","DOI":"10.1586\/erc.09.101"},{"key":"10.1160\/TH13-02-0084-6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908629"},{"key":"10.1160\/TH13-02-0084-7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908628"},{"key":"10.1160\/TH13-02-0084-8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.2002"},{"key":"10.1160\/TH13-02-0084-9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.04.008"},{"key":"10.1160\/TH13-02-0084-10","doi-asserted-by":"crossref","unstructured":"Gurbel PA, Bliden KP, Antonino MJ, et al. The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients. J Thromb Haemost 2010: 8: 43-53","DOI":"10.1111\/j.1538-7836.2009.03648.x"},{"key":"10.1160\/TH13-02-0084-11","doi-asserted-by":"crossref","unstructured":"Welsh RC, Rao SV, Zeymer U, et al., INNOVATE-PCI Investigators. A randomized double-blind active-controlled phase II trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial. Circ Cardiovasc Intervention 2012, 5: 336-346","DOI":"10.1161\/CIRCINTERVENTIONS.111.964197"},{"key":"10.1160\/TH13-02-0084-12","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-869525"},{"key":"10.1160\/TH13-02-0084-13","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000264509.36234.51"},{"key":"10.1160\/TH13-02-0084-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.09.025"},{"key":"10.1160\/TH13-02-0084-15","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.203414"},{"key":"10.1160\/TH13-02-0084-16","doi-asserted-by":"publisher","DOI":"10.1021\/jm800180e"},{"key":"10.1160\/TH13-02-0084-17","doi-asserted-by":"publisher","DOI":"10.1038\/nature11701"},{"key":"10.1160\/TH13-02-0084-18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60230-0"},{"key":"10.1160\/TH13-02-0084-19","doi-asserted-by":"crossref","unstructured":"Tricoci P, Huang Z, Held C, et al., for the TRACER investigators. Thrombin-receptor antagonist voraxapar in acute coronary syndromes. N Engl J Med 2012; 12: 366: 20-33","DOI":"10.1056\/NEJMoa1109719"},{"key":"10.1160\/TH13-02-0084-20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200933"},{"key":"10.1160\/TH13-02-0084-21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61269-0"},{"key":"10.1160\/TH13-02-0084-22","unstructured":"Kogushi M, Yokohama H, Kitamura S, et al. Effects of E5555, on inflammatory markers in vivo. J Thromb Haemost 2007; 5: Abstract P-M-059"},{"key":"10.1160\/TH13-02-0084-23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.021733"},{"key":"10.1160\/TH13-02-0084-24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.000786"},{"key":"10.1160\/TH13-02-0084-25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.001404"},{"key":"10.1160\/TH13-02-0084-26","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.670604"},{"key":"10.1160\/TH13-02-0084-27","first-page":"e138","volume":"28","author":"Chintala","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1160\/TH13-02-0084-28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2011.01.058"},{"key":"10.1160\/TH13-02-0084-29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.01944.x"},{"key":"10.1160\/TH13-02-0084-30","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000157668.39374.56"},{"key":"10.1160\/TH13-02-0084-31","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.106.476648"},{"key":"10.1160\/TH13-02-0084-32","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000232317.84122.0c"},{"key":"10.1160\/TH13-02-0084-33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07442-1"},{"key":"10.1160\/TH13-02-0084-34","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.150474"},{"key":"10.1160\/TH13-02-0084-35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1055\/s-0037-1619047","volume":"30","author":"Stoll","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1160\/TH13-02-0084-36","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.628867"},{"key":"10.1160\/TH13-02-0084-37","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2012.108"},{"key":"10.1160\/TH13-02-0084-38","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.03.011"},{"key":"10.1160\/TH13-02-0084-39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3882"},{"key":"10.1160\/TH13-02-0084-40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020945"},{"key":"10.1160\/TH13-02-0084-41","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.691279"},{"key":"10.1160\/TH13-02-0084-42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-180695"},{"key":"10.1160\/TH13-02-0084-43","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00971-6"},{"key":"10.1160\/TH13-02-0084-44","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.07.020"},{"key":"10.1160\/TH13-02-0084-45","unstructured":"Machin SJ, Clarke C, Ikemura O, et al. A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiCof activity and platelet adhesion in human volunteers. J Thromb Haemost 2003; 1: Abstract OC328"},{"key":"10.1160\/TH13-02-0084-46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.724864"},{"key":"10.1160\/TH13-02-0084-47","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.111.616649"},{"key":"10.1160\/TH13-02-0084-48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-317859"},{"key":"10.1160\/TH13-02-0084-49","doi-asserted-by":"crossref","unstructured":"Abd-Elaziz K, Kamphuisen PW, Lyssens C, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of anti-vWF nanobody ALX-0681 after single and multiple subcutaneous administrations to healthy volunteers. Blood 2009; 114: Abstract 1063","DOI":"10.1182\/blood.V114.22.1063.1063"},{"key":"10.1160\/TH13-02-0084-50","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-12-0804"},{"key":"10.1160\/TH13-02-0084-51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.4.459"},{"key":"10.1160\/TH13-02-0084-52","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000225697.98093.ed"},{"key":"10.1160\/TH13-02-0084-53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-06-2391"},{"key":"10.1160\/TH13-02-0084-54","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.189050"},{"key":"10.1160\/TH13-02-0084-55","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1096\/fj.03-0464fje","volume":"18","author":"Massberg","year":"2004","journal-title":"FASEB J"},{"key":"10.1160\/TH13-02-0084-56","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2010.04.009"},{"key":"10.1160\/TH13-02-0084-57","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvn169"},{"key":"10.1160\/TH13-02-0084-58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066960"},{"key":"10.1160\/TH13-02-0084-59","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-008-0722-3"},{"key":"10.1160\/TH13-02-0084-60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071193"},{"key":"10.1160\/TH13-02-0084-61","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000146341.63677.3C"},{"key":"10.1160\/TH13-02-0084-62","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.980623"},{"key":"10.1160\/TH13-02-0084-63","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000065604.56839.18"},{"key":"10.1160\/TH13-02-0084-64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.003"},{"key":"10.1160\/TH13-02-0084-65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.300271"},{"key":"10.1160\/TH13-02-0084-66","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000157439.49612.83"},{"key":"10.1160\/TH13-02-0084-67","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60600-4"},{"key":"10.1160\/TH13-02-0084-68","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1348-9"},{"key":"10.1160\/TH13-02-0084-69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03693.x"},{"key":"10.1160\/TH13-02-0084-70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04819.x"},{"key":"10.1160\/TH13-02-0084-71","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70198-8"},{"key":"10.1160\/TH13-02-0084-72","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.18.2018"},{"key":"10.1160\/TH13-02-0084-73","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16721-4"},{"key":"10.1160\/TH13-02-0084-74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1204133"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-02-0084.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T16:52:40Z","timestamp":1596646360000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-02-0084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-02-0084","relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}